GSK.L

GSK plc GSK.L

Bénéficiaire Individuel

Déclarant Citoyenneté ou lieu d'organisation Pouvoir de vote unique Pouvoir de vote partagé Pouvoir de disposition unique Pouvoir de disposition partagé Montant en propriété effective Pourcentage détenu Date d'achat
Dodge & Cox U.S.A. 96893740 0 102084740 0 102084740 5.8 % 13/02/2024
GSK plc England and Wales 16591937 0 16591937 0 16591937 7.4 % 06/02/2024
GSK plc England and Wales 13983761 0 13983761 0 13983761 11.5 % 06/02/2024
GSK plc England and Wales 1007583 0 1007583 0 1007583 4.9 % 06/02/2023
GSK plc England and Wales 10683761 0 10683761 0 10683761 10.95 % 30/01/2023
Dodge & U.S.A. 117971700 5.9 % 14/02/2022
GlaxoSmithKline plc England and Wales 8550954 0 8550954 0 8550954 6.5 % 10/02/2022
GlaxoSmithKline plc England and Wales 1785714 0 1785714 0 1785714 4.5 % 27/09/2021
GlaxoSmithKline plc England and Wales 1007583 0 1007583 0 1007583 5 % 12/07/2021
GlaxoSmithKline plc England and Wales 5217389 0 5217389 0 5217389 9.9 % 12/02/2021
GlaxoSmithKline plc England and Wales 2926957 0 2926957 0 2926957 3.4 % 12/02/2021
BlackRock, Inc. Delaware 326783307 0 377284263 0 377284263 7.5 % 29/01/2021
GlaxoSmithKline plc England and Wales 803922 0 803922 0 803922 8.9 % 30/11/2020
GlaxoSmithKline plc England and Wales 14935721 0 14935721 0 14935721 8.4 % 24/08/2020
GlaxoSmithKline plc England and Wales 6626027 0 6626027 0 6626027 6.03 % 04/05/2020
GlaxoSmithKline plc England and Wales 3676767 0 3676767 0 3676767 13.3 % 28/02/2020
GlaxoSmithKline plc England and Wales 1179941 0 1179941 0 1179941 4.1 % 14/02/2020
GlaxoSmithKline plc England and Wales 3676767 0 3676767 0 3676767 7.7 % 14/02/2020
GlaxoSmithKline plc England and Wales 10526957 0 10526957 0 10526957 12.5 % 14/02/2020
GlaxoSmithKline plc England and Wales 1785714 0 1785714 0 1785714 7.7 % 14/02/2020
BlackRock, Inc. Delaware 329746705 0 376159235 0 376159235 7.5 % 05/02/2020
GlaxoSmithKline plc 12455252 14.5 % 10/05/2019
GlaxoSmithKline plc England and Wales 14557004 0 14557004 0 14557004 12.7 % 25/02/2019
BlackRock, Inc. Delaware 320295965 0 344209770 0 344209770 6.9 % 04/02/2019
GlaxoSmithKline plc England and Wales 1179941 0 1179941 0 1179941 5.2 % 13/02/2018
BlackRock, Inc. Delaware 318875732 0 343209205 0 343209205 6.9 % 30/01/2018
BlackRock, Inc. Delaware 290550171 0 315534728 0 315534728 6.4 % 23/01/2017
GlaxoSmithKline plc England and Wales 545006 0 545006 0 545006 3.9 % 09/02/2016
GlaxoSmithKline plc England and Wales 8343792 0 8343792 0 8343792 22.1 % 09/02/2016
BlackRock, Inc. Delaware 277533363 27964 300144656 27964 300172620 6.2 % 26/01/2016
GlaxoSmithKline plc England and Wales 8299218 0 8299218 0 8299218 24.5 % 02/09/2015
GlaxoSmithKline plc England and Wales 1476203 0 1476203 0 1476203 3 % 12/02/2015
GlaxoSmithKline plc England and Wales 1356533 0 1356533 0 1356533 7.5 % 12/02/2015
BlackRock, Inc. Delaware 258081385 0 288448327 0 288448327 5.9 % 30/01/2015
GlaxoSmithKline plc England and Wales 0 0 0 0 0 0 % 28/10/2014
GlaxoSmithKline plc England and Wales 545009 0 545009 0 545009 6.2 % 15/05/2014
GlaxoSmithKline plc England and Wales 0 0 0 0 0 0 % 24/02/2014
GlaxoSmithKline plc England and Wales 4183652 0 4183652 0 4183652 12 % 14/02/2014
GlaxoSmithKline plc England and Wales 3360467 0 3360467 0 3360467 7.8 % 14/02/2014
GlaxoSmithKline plc England and Wales 2607546 0 2607546 0 2607546 9.4 % 14/02/2014
GlaxoSmithKline plc England and Wales 11315825 0 11315825 0 11315825 17.6 % 14/02/2014
BlackRock, Inc. Delaware 253606384 117636 285206852 117636 285324488 5.9 % 11/02/2014

Senat trading

Bureau Date de la transaction Date de réception Type Montant Commentaire

Senat Divulgation

Représentant Date de la transaction Date de divulgation Type Montant District